To anticipate the potential efficacy of PIs in leukemia cells, understanding of the proteasome subunit composition is of relevance, as unlike solid tumors, the dominant fraction (>70%) is composed of iP subunits rather than cP subunits [6,11,41,50]. The gene discussed is CP; the disease is leukemia.